Cadian Capital Management, LP Maxcyte, Inc. Transaction History
Cadian Capital Management, LP
- $2.34 Billion
- Q1 2025
A detailed history of Cadian Capital Management, LP transactions in Maxcyte, Inc. stock. As of the latest transaction made, Cadian Capital Management, LP holds 10,027,727 shares of MXCT stock, worth $22.5 Million. This represents 1.17% of its overall portfolio holdings.
Number of Shares
10,027,727
Previous 9,344,424
7.31%
Holding current value
$22.5 Million
Previous $38.9 Million
29.58%
% of portfolio
1.17%
Previous 2.26%
Shares
6 transactions
Others Institutions Holding MXCT
# of Institutions
118Shares Held
71.6MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY8.14MShares$18.2 Million0.0% of portfolio
-
Morgan Stanley New York, NY7MShares$15.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.57MShares$12.5 Million0.0% of portfolio
-
Vitruvian Partners LLP5.04MShares$11.3 Million13.13% of portfolio
-
Mirabella Financial Services LLP London, X03.7MShares$8.29 Million0.43% of portfolio
About MAXCYTE, INC.
- Ticker MXCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 101,724,000
- Market Cap $228M
- Description
- MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...